Keloids Treatment Market Size Growth: From $4.48 Billion In 2026 To $5.37 Billion By 2030

Keloids Treatment Market Report

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Keloids Treatment Market Revenue Outlook: What CAGR Lies Ahead Through 2030?

The keloids treatment market size has demonstrated steady growth in recent years. It is projected to expand from $4.32 billion in 2025 to $4.48 billion in 2026, achieving a compound annual growth rate (CAGR) of 3.7%. This expansion observed in the past can be attributed to a rising occurrence of skin injuries and surgical procedures, an increasing prevalence of populations susceptible to keloids, the established application of steroid injections, a growing desire for cosmetic dermatology treatments, and the availability of multiple treatment options.

The keloids treatment market is projected to experience consistent expansion in the coming years, reaching a valuation of $5.37 billion by 2030, driven by a compound annual growth rate (CAGR) of 4.6%. This anticipated growth over the forecast period is attributable to several factors, including advancements in laser and cryotherapy technologies, an increasing awareness regarding scar management solutions, a growing inclination towards minimally invasive treatments, the expansion of dermatology clinics within emerging markets, and the rising uptake of homecare scar products. Key trends anticipated during this period encompass a heightened demand for non-invasive keloid treatments, an increasing embrace of combination therapy methods, expanded utilization of laser-based scar management techniques, the broader availability of homecare and topical treatment choices, and a strong emphasis on personalized therapies aimed at preventing recurrence.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=56406702&type=smp&name=Keloids%20Treatment%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Keloids Treatment Market Demand Drivers: What’s Powering Industry Growth?

The growing number of wound and injury incidents is projected to drive expansion within the Keloid Treatment Market. A wound refers to a physical harm or damage to the body’s tissues, typically involving a rupture in the skin, stemming from various factors such as mishaps, surgical interventions, burns, or other traumatic occurrences. The increase in such wounds often results in keloid formation, consequently heightening the need for effective treatment solutions, improving awareness regarding keloid complications, encouraging research breakthroughs, and fostering cooperation among medical professionals. For example, in November 2024, the U.S. Bureau of Labor Statistics (BLS), a US-based federal government body that provides essential labor market and workplace safety information, indicated that private industry employers recorded around 2.6 million nonfatal workplace injuries and illnesses in 2023. Therefore, the increasing occurrence of wound and injury cases will propel the growth of the Keloid Treatment Market. The growing fascination with non-surgical aesthetic procedures is anticipated to advance the Keloid Treatment Market. Non-surgical aesthetics refer to cosmetic therapies that improve one’s appearance without requiring surgery, addressing particular concerns for a more youthful look. Medical practitioners utilize non-surgical aesthetic interventions such as laser therapy, cryotherapy, and dermal fillers to diminish the visibility and alleviate symptoms of keloid scars, thereby lessening inflammation, redness, and vascularization. For example, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based nonprofit organization comprising board-certified plastic surgeons, reported that overall surgical and non-surgical aesthetic procedures collectively increased by 3.4% in 2023, totaling around 34.9 million, with approximately 19.1 million of these being non-surgical treatments. Consequently, the escalating demand for non-surgical aesthetic procedures will stimulate the Keloid Treatment Market.

Keloids Treatment Market Breakdown By Product Type And Application

The keloids treatment market covered in this report is segmented –

1) By Product Type: Topical Products, Injectable Products, Medical Devices

2) By Treatment: Radiation Therapy, Cryo Therapy, Surgical Treatment, Laser Treatment, Steroid Injections, Other Treatments

3) By Route Of Administration: Topical Administration, Intralesional Administration

4) By End User: Hospitals, Homecare, Dermatology Clinics, Other End Users

Subsegments:

1) By Topical Products: Silicone-Based Products, Steroid-Based Topical Products

2) By Injectable Products: Corticosteroid Injections, Antimetabolite Injections

3) By Medical Devices: Compression Therapy Devices, Silicone-Based Scar Management Devices

Keloids Treatment Market Innovation Trends: What Developments Are Reshaping The Industry?

Major companies operating in the keloid treatment market are concentrating on developing innovative scar management technologies, such as scar-erase silicone strips, to achieve competitive advantages. For example, in April 2023, Scar Erase, a UK-based scar treatment company, launched Scar Erase silicone strips as a solution for treating scars. These strips are constructed from 3 mm of medical-grade silicone and have been clinically proven to enhance scar appearance and facilitate healing. These reusable, vegan, and cruelty-free technology strips are engineered to provide an affordable and convenient at-home scar treatment option, applicable to various scar types including hypertrophic, keloid, post-surgery, and stretch marks. The process further involves encapsulating the scar with silicone to hydrate it and foster an optimal healing environment. This approach reduces collagen formation and improves scar texture, color, and height, offering both effectiveness and comfort.

Keloids Treatment Market Company Landscape And Competitive Strategy

Major companies operating in the keloids treatment market are Galderma S.A., Sun Pharmaceutical Industries Ltd., Stratpharma AG, Revance Therapeutics Inc., Sensus Healthcare Inc., Cynosure Inc., Cutera Inc., Lumenis Ltd., Candela Medical, Merz Pharma GmbH & Co. KGaA, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Alliance Pharma plc, Sonoma Pharmaceuticals Inc., Strata Skin Sciences Inc., Avita Medical Limited, Biofrontera AG, Sinclair Pharma plc, Fotona d.o.o., Lutronic Corporation

View The Full Keloids Treatment Market Report:

https://thebusinessresearchcompany.com/report/keloids-treatment-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Keloids Treatment Market Global Footprint: Which Region Leads The Market?

North America was the largest region in the keloids treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the keloids treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model